Acta Med. 2012, 55: 74-77
https://doi.org/10.14712/18059694.2015.58
Preoperative Serum Levels of Soluble Endoglin for Prediction of Recurrence in Stage III Colorectal Cancer Patients
Crossref Cited-by Linking
- Laukhtina Ekaterina, Schuettfort Victor M., D'Andrea David, Pradere Benjamin, Mori Keiichiro, Quhal Fahad, Sari Motlagh Reza, Mostafaei Hadi, Katayama Satoshi, Grossmann Nico С., Rajwa Pawel, Zeinler Flora, Abufaraj Mohammad, Moschini Marco, Zimmermann Kristin, Karakiewicz Pierre I., Fajkovic Harun, Scherr Douglas, Compérat Eva, Nyirady Peter, Rink Michael, Enikeev Dmitry, Shariat Shahrokh F.: Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder. Molecular Carcinogenesis 2022, 61, 5. <https://doi.org/10.1002/mc.23355>
- Nogués Ana, Gallardo-Vara Eunate, Zafra Mª. Paz, Mate Paloma, Marijuan Jose Luis, Alonso Alfredo, Botella Luisa Mª., Prieto Mª. Isabel: Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer. World J Surg Onc 2020, 18. <https://doi.org/10.1186/s12957-020-01871-2>
- Reumer Ank, Maes Evelyne, Mertens Inge, Cho William CS, Landuyt Bart, Valkenborg Dirk, Schoofs Liliane, Baggerman Geert: Colorectal cancer biomarker discovery and validation using LC-MS/MS-based proteomics in blood: truth or dare?. Expert Review of Proteomics 2014, 11, 449. <https://doi.org/10.1586/14789450.2014.905743>